Empresa InMed Pharmaceuticals Inc. Toronto S.E.
Acciones
IN
CA4576376012
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 13
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
BayMedica
100,0
%
| 1 | 100,0 % | 4 | 100,0 % | +279,61 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 4 | 100,0 % | +279,61 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Eric Adams
CEO | Chief Executive Officer | 61 | 16/06/16 |
Chief Operating Officer | - | 05/11/18 | |
Colin Clancy
IRC | Investor Relations Contact | - | - |
Gerard Griffin
SAM | Sales & Marketing | - | 01/02/22 |
Eric Hsu
PRN | Corporate Officer/Principal | - | 13/03/18 |
General Counsel | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Janet Grove
BRD | Director/Board Member | 57 | 11/02/22 |
Eric Adams
CEO | Chief Executive Officer | 61 | 16/06/16 |
Andrew Hull
CHM | Chairman | 61 | 12/09/16 |
Bryan Baldasare
BRD | Director/Board Member | 58 | 12/05/22 |
Nicole Lemerond
BRD | Director/Board Member | 48 | 08/08/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 14 137 034 | 14 054 505 ( 99,42 %) | 0 | 99,42 % |
Información de la empresa
InMed Pharmaceuticals, Inc.
815 West Hastings Street Suite 310
V6C 1B4, Vancouver
+604 669 7207
http://www.inmedpharma.com![Dirección InMed Pharmaceuticals Inc.(IN)](https://cdn.zonebourse.com/static/address/42503446.png)
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+16,39 % | 121 mil M | |
+18,10 % | 110 mil M | |
+17,38 % | 25,98 mil M | |
-24,30 % | 19,27 mil M | |
-18,72 % | 15,99 mil M | |
-17,96 % | 15,66 mil M | |
-48,32 % | 14,5 mil M | |
+57,17 % | 14,47 mil M | |
+4,98 % | 13,91 mil M |